 |
Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases.
Mathew, P., Wen, S., Morita, S., Thall, P.F.
|
J Interferon Cytokine Res. |
2011 |
|
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.
Mita, A.C., Takimoto, C.H., Mita, M., Tolcher, A., Sankhala, K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y.N., Zhong, Z.D., Bass, M.B., Le, N., LoRusso, P.
|
Clinical Cancer Research |
2010 |
|
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
Horowitz, N.S., Penson, R.T., Duda, D.G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Cohen, K.S., Berlin, S., Krasner, C.N., Moses, M.A., Jain, R.K.
|
Clin Ovarian Cancer Other Gynecol Malig. |
2011 |
|
Evaluation of KRAS mutations, angiogenic biomarkers and DCE-MRI in patients with advanced non-small cell lung cancer receiving sorafenib.
Kelly, R.J., Rajan, A., Force, J., Keen, C., Cao, L., Yu, Y., Choyke, P.L., Turkbey, B., Raffeld, M., Xi, L., Steinberg, S.M., Wright, J.J., Lopez-Chavez, A., Kummar, S., Guttierrez, M., Giaccone, G.
|
Clin Cancer Res. |
2011 |
|
Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases.
Mathew, P., Wen, S., Morita, S., Thall, P.F.
|
J Interferon Cytokine Res. |
2011 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
20 plates |
| Catalog No. |
K151BLA-3 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K151BLA-3
